Is JSPR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for JSPR. It does not provide personalized investment advice.

JSPR (Jasper Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Jasper Therapeutics, Inc. Common Stock (JSPR) is a publicly traded Healthcare sector company. As of September 4, 2026, JSPR trades at $0.73 with a market cap of $22.84M and a P/E ratio of -0.17. JSPR moved +1.63% today. Year to date, JSPR is -61.28%; over the trailing twelve months it is -73.95%. Its 52-week range spans $0.32 to $7.19. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces JSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are JSPR's key financials?

JSPR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. JSPR recently traded at $0.73. Market cap is $22.84M. P/E ratio is -0.17. Revenue is $0.

JSPR Key Metrics

Key financial metrics for JSPR
Metric	Value
Price	$0.73
Market Cap	$22.84M
P/E Ratio	-0.17
EPS	$-3.95
Dividend Yield	0.00%
52-Week High	$7.19
52-Week Low	$0.32
Volume	430.37K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-75.80M
Gross Margin	0.00%

JSPR Analyst Consensus

3 analysts cover JSPR: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.

Common questions about JSPR

What are JSPR's key financials?: JSPR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. JSPR recently traded at $0.73. Market cap is $22.84M. P/E ratio is -0.17. Revenue is $0.
Is JSPR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for JSPR. It does not provide personalized investment advice.